EFFICACY OF TEZEPELUMAB IN PATIENTS WITH LOW AND HIGH BRONCHODILATOR REVERSIBILITY IN PATHWAY

被引：0
|
作者：
Corren, J. [1 ]
Liu, M. C. [2 ]
Bowen, K. [3 ]
Salapa, K. [4 ]
Colice, G. [3 ]
Llanos-Ackert, J. P. [5 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA
[3] AstraZeneca, Gaithersburg, MD USA
[4] AstraZeneca, Warsaw, Poland
[5] Amgen Inc, Thousand Oaks, CA USA
来源：
THORAX | 2021年 / 76卷
关键词：
D O I：
10.1136/thorax-2020-BTSabstracts.144
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
S139
引用
收藏
页码：A83 / A84
页数：2
相关论文
共 50 条
  • [31] Residual reversibility in COPD patients already on long-acting bronchodilator: The OscilloRevers Study
    Le Rouzic, Olivier
    Picaud, Marjorie
    Salvator, Helene
    Bautin, Nathalie
    Devillier, Philippe
    Perez, Thierry
    RESPIRATORY MEDICINE AND RESEARCH, 2024, 85
  • [32] Bronchodilator reversibility among patients with asthma presenting to tertiary care hospitals in Trivandrum, India
    Nair, Sanjeev
    Arjun, Padmanabhan
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [33] Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation
    Maniscalco, Mauro
    Ambrosino, Pasquale
    Fuschillo, Salvatore
    Stufano, Silvia
    Sanduzzi, Alessandro
    Matera, Maria Gabriella
    Cazzola, Mario
    RESPIRATORY MEDICINE, 2021, 182
  • [34] What is the Best Way to Diagnose Possible Asthma Patients with Negative Bronchodilator Reversibility Tests?
    Akdogan, Buket Basa
    Kalkan, Ilkay Koca
    Buhari, Gozde Koycu
    Ozdedeoglu, Ozlem
    Ates, Hale
    Aksu, Kurtulus
    Erkekol, Ferda Oner
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 113 - 122
  • [35] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH UNCONTROLLED ASTHMA DESPITE RECEIVING TREATMENT FOR MODERATE OR SEVERE DISEASE: POOLED ANALYSIS OF PATHWAY AND NAVIGATOR STUDIES
    Corren, Jonathan
    Wechsler, Michael E.
    Chupp, Geoffrey L.
    Ambrose, Christopher
    Roseti, Stephanie L.
    Hellqvist, Asa
    Ackert, Jean-Pierre Llanos
    Martin, Neil
    Colice, Gene L.
    CHEST, 2022, 162 (04) : 21A - 22A
  • [36] Pre- and post-bronchodilator spirometric values and the degree of reversibility in patients with COPD
    Lee, DKC
    EUROPEAN RESPIRATORY JOURNAL, 2004, 24 (02) : 332 - 332
  • [37] Unlocking Nanoprecipitation: A Pathway to High Reversibility in Nanofluidic Memristors
    Laucirica, Gregorio
    Toimil-Molares, Maria Eugenia
    Marmisolle, Waldemar Alejandro
    Azzaroni, Omar
    ACS APPLIED MATERIALS & INTERFACES, 2024, 16 (43) : 58818 - 58826
  • [38] Influence of baseline bronchodilator reversibility and blood eosinophils on lung function in patients with asthma following omalizumab
    Casale, Thomas B.
    Chipps, Bradley E.
    Iqbal, Ahmar
    Yoo, Bongin
    Millette, Lauren A.
    Hanania, Nicola A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (02): : 512 - 514.e2
  • [39] The predictive values of bronchodilator reversibility indicators in asthmatic patients with non-obstructive patterns of spirometry
    Merghani, Tarig
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [40] Efficacy of Tezepelumab in Patients Grouped by Pre-treatment Percent Predicted FEV1: A Pooled Analysis of the PATHWAY and NAVIGATOR Studies
    Wechsler, M. E.
    Ambrose, C. S.
    Cook, W.
    Ackert, J. Llanos
    Martin, N.
    Molfino, N. A.
    McKellar, D.
    White, T.
    Colice, G.
    Menzies-Gow, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
12345